Sunflower Pharmaceutical Group Co., Ltd. (SHE:002737)
China · Delayed Price · Currency is CNY 11.53
-0.17 (-1.45%)
Sep 10, 2026, 12:45 PM CST
SHE:002737 Revenue
Sunflower Pharmaceutical Group had revenue of 654.04M CNY in the quarter ending June 30, 2026, with 1.14% growth. This brings the company's revenue in the last twelve months to 2.51B, up 16.03% year-over-year. In the year 2025, Sunflower Pharmaceutical Group had annual revenue of 2.32B, down -31.36%.
Revenue (ttm)
2.51B
Revenue Growth
+16.03%
P/S Ratio
2.73
Revenue / Employee
498.66K
Employees
5,025
Market Cap
6.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.32B | -1.06B | -31.36% |
| Dec 31, 2024 | 3.38B | -2.32B | -40.76% |
| Dec 31, 2023 | 5.70B | 605.78M | 11.89% |
| Jan 1, 2023 | 5.09B | 633.61M | 14.20% |
| Jan 1, 2022 | 4.46B | 999.01M | 28.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.